AR053760A1 - Procedimiento de preparacion de derivados de diarilcicloalquilo y compuestos intermediarios - Google Patents

Procedimiento de preparacion de derivados de diarilcicloalquilo y compuestos intermediarios

Info

Publication number
AR053760A1
AR053760A1 ARP050103522A ARP050103522A AR053760A1 AR 053760 A1 AR053760 A1 AR 053760A1 AR P050103522 A ARP050103522 A AR P050103522A AR P050103522 A ARP050103522 A AR P050103522A AR 053760 A1 AR053760 A1 AR 053760A1
Authority
AR
Argentina
Prior art keywords
compound
formula
alkyl
reacted
atoms
Prior art date
Application number
ARP050103522A
Other languages
English (en)
Spanish (es)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of AR053760A1 publication Critical patent/AR053760A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/03—Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/62—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems having two or more ring systems containing condensed 1,3-oxazole rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP050103522A 2004-08-23 2005-08-22 Procedimiento de preparacion de derivados de diarilcicloalquilo y compuestos intermediarios AR053760A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004040736A DE102004040736B4 (de) 2004-08-23 2004-08-23 Verfahren zur Herstellung von Diarylcycloalkylderivaten

Publications (1)

Publication Number Publication Date
AR053760A1 true AR053760A1 (es) 2007-05-23

Family

ID=35745474

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050103522A AR053760A1 (es) 2004-08-23 2005-08-22 Procedimiento de preparacion de derivados de diarilcicloalquilo y compuestos intermediarios

Country Status (27)

Country Link
US (2) US7803950B2 (cg-RX-API-DMAC7.html)
EP (1) EP1786913B1 (cg-RX-API-DMAC7.html)
JP (1) JP4991543B2 (cg-RX-API-DMAC7.html)
KR (1) KR20070048741A (cg-RX-API-DMAC7.html)
CN (1) CN101014714B (cg-RX-API-DMAC7.html)
AR (1) AR053760A1 (cg-RX-API-DMAC7.html)
AT (1) ATE520785T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005276642B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514000A (cg-RX-API-DMAC7.html)
CA (1) CA2578342A1 (cg-RX-API-DMAC7.html)
CY (1) CY1112080T1 (cg-RX-API-DMAC7.html)
DE (1) DE102004040736B4 (cg-RX-API-DMAC7.html)
DK (1) DK1786913T3 (cg-RX-API-DMAC7.html)
ES (1) ES2371762T3 (cg-RX-API-DMAC7.html)
IL (1) IL181339A0 (cg-RX-API-DMAC7.html)
MA (1) MA28796B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007001872A (cg-RX-API-DMAC7.html)
NO (1) NO20071316L (cg-RX-API-DMAC7.html)
NZ (1) NZ553602A (cg-RX-API-DMAC7.html)
PL (1) PL1786913T3 (cg-RX-API-DMAC7.html)
PT (1) PT1786913E (cg-RX-API-DMAC7.html)
RU (1) RU2414459C2 (cg-RX-API-DMAC7.html)
SI (1) SI1786913T1 (cg-RX-API-DMAC7.html)
TW (1) TW200621734A (cg-RX-API-DMAC7.html)
UY (1) UY29082A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006021420A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200700635B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
CN101381302B (zh) * 2007-09-07 2013-04-03 上海睿智化学研究有限公司 2-溴甲基-6-甲基苯甲酰氯/溴的制备方法
CA2710538A1 (en) * 2008-01-25 2009-07-30 Xenoport, Inc. Crystalline form of a (3s)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728899A (en) * 1995-03-27 1998-03-17 Hoechst Marion Roussel Inc. Preparation of cis-4-O-protected-2-cyclopentenol derivatives
BR0212158A (pt) * 2001-08-31 2004-07-13 Aventis Pharma Gmbh Derivados de diarilcicloalquila, processos para a sua preparação e sua aplicação como ativadores de ppar
US6884812B2 (en) * 2001-08-31 2005-04-26 Aventis Pharma Deutschland Gmbh Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
WO2003072100A1 (en) * 2002-02-25 2003-09-04 Eli Lilly And Company Peroxisome proliferator activated receptor modulators
DE10308353A1 (de) * 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7094795B2 (en) * 2003-02-27 2006-08-22 Sanofi-Aventis Deutschland Gmbh Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives
DE10308350B4 (de) * 2003-02-27 2006-06-01 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 1,3-Cyclohexandiol-Derivaten
WO2005040394A1 (fr) * 2003-10-22 2005-05-06 Rhodia Chimie Procede de fabrication de compose comprenant un groupement hydroxyle libre et un groupement hydroxyle protégé par une fonction ester par reaction enzymatique
DE102004038403B4 (de) * 2004-08-07 2006-08-31 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 3-Hydroxycyclohexancarbonsäure-Derivaten

Also Published As

Publication number Publication date
SI1786913T1 (sl) 2011-12-30
WO2006021420A2 (de) 2006-03-02
KR20070048741A (ko) 2007-05-09
US20080051583A1 (en) 2008-02-28
JP2008510761A (ja) 2008-04-10
ATE520785T1 (de) 2011-09-15
DE102004040736A1 (de) 2006-03-02
UY29082A1 (es) 2006-03-31
DE102004040736B4 (de) 2007-01-11
EP1786913B1 (de) 2011-08-17
AU2005276642A1 (en) 2006-03-02
MX2007001872A (es) 2007-04-24
EP1786913A2 (de) 2007-05-23
DK1786913T3 (da) 2011-11-28
BRPI0514000A (pt) 2008-05-20
WO2006021420A3 (de) 2006-12-21
NO20071316L (no) 2007-05-22
US7803950B2 (en) 2010-09-28
RU2414459C2 (ru) 2011-03-20
CA2578342A1 (en) 2006-03-02
ZA200700635B (en) 2010-01-27
NZ553602A (en) 2010-04-30
ES2371762T3 (es) 2012-01-09
MA28796B1 (fr) 2007-08-01
PT1786913E (pt) 2011-10-31
PL1786913T3 (pl) 2012-01-31
RU2007110644A (ru) 2008-09-27
IL181339A0 (en) 2007-07-04
CN101014714B (zh) 2012-05-23
TW200621734A (en) 2006-07-01
WO2006021420B1 (de) 2007-02-08
JP4991543B2 (ja) 2012-08-01
AU2005276642B2 (en) 2011-12-22
US20070197614A1 (en) 2007-08-23
CY1112080T1 (el) 2015-11-04
CN101014714A (zh) 2007-08-08

Similar Documents

Publication Publication Date Title
ES2653613T3 (es) Procedimiento para la preparación de derivados de carbamato de fenilo
ES2393692T3 (es) Método para la preparación de dabigatran y sus intermedios
ECSP034475A (es) Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
IS7947A (is) Aðferð til að framleiða kristölluð form ljósfræðilegra handhverfa módafíníls
MX2019003144A (es) Proceso para preparar 2-exo-(2-metilbenciloxi)-1-metil-4-isopropil -7-oxabiciclo[2.2.1]heptano.
PE20060583A1 (es) Tiazolil-dihidro-indazoles como inhibidores de pi3-quinasas
AR057033A1 (es) Tigeciclina y metodos para preparar 9-nitrominociclina
AR071744A1 (es) Proceso para la preparacion de 6-sustituido-1-(2h)-isoquinolinonas, intermediarios para su sintesis y metodos de obtencion de estos intermediarios.
AR076615A1 (es) Metodo para producir microcapsulas
AR051373A1 (es) Procedimiento para la preparacion de analogos aciclicos de nucleotidos de fosfonatos
DD266097A5 (de) Verfahren zur herstellung einer sulfonsaeureester
RU2011141209A (ru) Усовершенствованный способ получения ингибиторов дипептидиллептизады-iv и промежуточного соединения
EP2891647A1 (en) Method for producing (r)-1,1,3-trimethyl-4-aminoindane
AR030938A1 (es) Proceso de obtencion de los enantiomeros de la cetamina racemica; proceso de obtencion de sales farmaceuticamente aceptables de enantiomeros de la cetamina racemica y utilizacion de las sales farmaceuticamente aceptables obtenidas por el referido proceso
CA2994830A1 (en) Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols
AR072776A1 (es) Procesos para la produccion de 2-amino-2-[2-(4-alquil c2-20-fenil)etil]propano-1,3-dioles y a compuestos intermediarios para usar con los mismos
AR065154A1 (es) Procedimiento de preparacion de sulfanilamidas y sulfinamidinas fluoradas y sus utilizaciones
RU2013150969A (ru) Промежуточное соединение для синтеза каспофунгина и способ его получения
AR049668A1 (es) Proceso quimico para preparar esteres de 4,4 - difluorometil - 3 - oxo - butanoico por reaccion entre una amida y un ester.
CO2023012775A2 (es) Proceso químico
AR056262A1 (es) Preparacion de alcoholes propargilicos y esteres intermediarios de analogos de himbacina
SE8102525L (sv) Forfarande for framstellning av cyklopropankarboxylsyraester-derivat
ES2982231T3 (es) Estereotetradas escalables de polipropionato lactona
AR129159A1 (es) Compuestos de nitróxido y sus usos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal